Frontiers in Bioscience-Landmark

Frontiers in Bioscience-Landmark

Journal Cover
P-ISSN: 2768-6701
E-ISSN: 2768-6698
Frontiers in Bioscience-Landmark (FBL) is an international, peer-reviewed, open-access bioscience journal focused on cellular and molecular biology. FBL is dedicated to publishing advances in all aspects of cellular and molecular biology of eukaryotic and prokaryotic cells, including studies related to biochemistry, biophysics, physiology, pathology, biotechnology, bioinformatics, and other related fields. The journal provides a platform for delivering scientific information to investigators, scientists, physicians, lecturers, and students. FBL welcomes submissions of original research articles, reviews, systematic reviews, short communications, and editorials.
Frontiers in Bioscience-Landmark (FBL) is an international, peer-reviewed, open-access bioscience journal focused on cellular and molecular biology. FBL is dedicated to publishing advances in all aspects of cellular and molecular biology of eukaryotic and prokaryotic cells, including studies related to biochemistry, biophysics, physiology, pathology, biotechnology, bioinformatics, and other related fields. The journal provides a platform for delivering scientific information to investigators, scientists, physicians, lecturers, and students. FBL welcomes submissions of original research articles, reviews, systematic reviews, short communications, and editorials.
5 Days
Time to First Decision
 
35 Days
Review Time
 
75 Days
Submission to Acceptance
Journal Cover
P-ISSN: 2768-6701
E-ISSN: 2768-6698
Frontiers in Bioscience-Landmark (FBL) is an international, peer-reviewed, open-access bioscience journal focused on cellular and molecular biology. FBL is dedicated to publishing advances in all aspects of cellular and molecular biology of eukaryotic and prokaryotic cells, including studies related to biochemistry, biophysics, physiology, pathology, biotechnology, bioinformatics, and other related fields. The journal provides a platform for delivering scientific information to investigators, scientists, physicians, lecturers, and students. FBL welcomes submissions of original research articles, reviews, systematic reviews, short communications, and editorials.
Frontiers in Bioscience-Landmark (FBL) is an international, peer-reviewed, open-access bioscience journal focused on cellular and molecular biology. FBL is dedicated to publishing advances in all aspects of cellular and molecular biology of eukaryotic and prokaryotic cells, including studies related to biochemistry, biophysics, physiology, pathology, biotechnology, bioinformatics, and other related fields. The journal provides a platform for delivering scientific information to investigators, scientists, physicians, lecturers, and students. FBL welcomes submissions of original research articles, reviews, systematic reviews, short communications, and editorials.
5 Days
Time to First Decision
 
35 Days
Review Time
 
75 Days
Submission to Acceptance

Highlights

Editor's Pick

View All
Open Access Review
2950
539
18
Open Access Original Research

Oxidative and Excitatory Neurotoxic Stresses in CRISPR/Cas9-Induced Kynurenine Aminotransferase Knockout Mice: A Novel Model for Despair-Based Depression and Post-Traumatic Stress Disorder

Ágnes Szabó, Zsolt Galla, Eleonóra Spekker, Mónika Szűcs, Diána Martos, Keiko Takeda, Kinuyo Ozaki, Hiromi Inoue, Sayo Yamamoto, József Toldi, Etsuro Ono, László Vécsei, Masaru Tanaka

Front. Biosci. (Landmark Ed) 2025, 30(1), 25706; https://doi.org/10.31083/FBL25706

(This article belongs to the Special Issue Exploring Pathomechanisms, Novel Targets, and New Interventions for Neurological and Neuropsychiatric Disorders)

2330
396
18

Editor's Pick

View All
Open Access Review
2950
539
18
Open Access Original Research

Oxidative and Excitatory Neurotoxic Stresses in CRISPR/Cas9-Induced Kynurenine Aminotransferase Knockout Mice: A Novel Model for Despair-Based Depression and Post-Traumatic Stress Disorder

Ágnes Szabó, Zsolt Galla, Eleonóra Spekker, Mónika Szűcs, Diána Martos, Keiko Takeda, Kinuyo Ozaki, Hiromi Inoue, Sayo Yamamoto, József Toldi, Etsuro Ono, László Vécsei, Masaru Tanaka

Front. Biosci. (Landmark Ed) 2025, 30(1), 25706; https://doi.org/10.31083/FBL25706

(This article belongs to the Special Issue Exploring Pathomechanisms, Novel Targets, and New Interventions for Neurological and Neuropsychiatric Disorders)

2330
396
18
Latest Articles
Most Read
Funding
Open Access Review

Keap1-Nrf2 Signaling Pathway-Mediated Antioxidant Defense in Neurodegenerative Diseases: Mechanisms and Traditional Chinese Medicine Therapeutic Strategies

Wentao Chen, Jiying Wang, Qing Li, Linao Zhang, Xue Wu, Shifang Luo, Yuhuan Xie, Peixin Guo

Front. Biosci. (Landmark Ed) 2026, 31(4), 45233; https://doi.org/10.31083/FBL45233 (registering DOI)

(This article belongs to the Special Issue Exploring Pathomechanisms, Novel Targets, and New Interventions of Neurological and Neuropsychiatric Disorders - Volume 2)

9
2
Open Access Review
4
2
Open Access Original Research
5
2
Open Access Review
3
2
Open Access Opinion
44
6
Open Access Original Research
62
2
Open Access Original Research
78
3
View All

Journal Metrics

Icon Metrics
Impact Factor3.1
CiteScore4.5
Frequency12 issues per year
Establish Year1996

Icon Indexing

Journal Metrics

Icon Metrics
Impact Factor3.1
CiteScore4.5
Frequency12 issues per year
Establish Year1996

Icon Indexing

Email Alert

Add your e-mail address to receive forthcoming issues of this journal:

Subscribe

Editorial Board

View All
  • Portrait of Editorial Board member Graham Pawelec

    Graham Pawelec

    Editor-in-Chief

    cancer immunotherapy; immune monitoring; vaccination; immune ageing in humans

Editorial Board

  • Portrait of Editorial Board member Graham Pawelec

    Graham Pawelec

    Editor-in-Chief

    cancer immunotherapy; immune monitoring; vaccination; immune ageing in humans

View All

Membership

Membership

Follow Us

Frontiers in Bioscience-Landmark

Frontiers in Bioscience-Landmark

Journal Cover
P-ISSN: 2768-6701
E-ISSN: 2768-6698
Frontiers in Bioscience-Landmark (FBL) is an international, peer-reviewed, open-access bioscience journal focused on cellular and molecular biology. FBL is dedicated to publishing advances in all aspects of cellular and molecular biology of eukaryotic and prokaryotic cells, including studies related to biochemistry, biophysics, physiology, pathology, biotechnology, bioinformatics, and other related fields. The journal provides a platform for delivering scientific information to investigators, scientists, physicians, lecturers, and students. FBL welcomes submissions of original research articles, reviews, systematic reviews, short communications, and editorials.
Frontiers in Bioscience-Landmark (FBL) is an international, peer-reviewed, open-access bioscience journal focused on cellular and molecular biology. FBL is dedicated to publishing advances in all aspects of cellular and molecular biology of eukaryotic and prokaryotic cells, including studies related to biochemistry, biophysics, physiology, pathology, biotechnology, bioinformatics, and other related fields. The journal provides a platform for delivering scientific information to investigators, scientists, physicians, lecturers, and students. FBL welcomes submissions of original research articles, reviews, systematic reviews, short communications, and editorials.
5 Days
Time to First Decision
 
35 Days
Review Time
 
75 Days
Submission to Acceptance
Journal Cover
P-ISSN: 2768-6701
E-ISSN: 2768-6698
Frontiers in Bioscience-Landmark (FBL) is an international, peer-reviewed, open-access bioscience journal focused on cellular and molecular biology. FBL is dedicated to publishing advances in all aspects of cellular and molecular biology of eukaryotic and prokaryotic cells, including studies related to biochemistry, biophysics, physiology, pathology, biotechnology, bioinformatics, and other related fields. The journal provides a platform for delivering scientific information to investigators, scientists, physicians, lecturers, and students. FBL welcomes submissions of original research articles, reviews, systematic reviews, short communications, and editorials.
Frontiers in Bioscience-Landmark (FBL) is an international, peer-reviewed, open-access bioscience journal focused on cellular and molecular biology. FBL is dedicated to publishing advances in all aspects of cellular and molecular biology of eukaryotic and prokaryotic cells, including studies related to biochemistry, biophysics, physiology, pathology, biotechnology, bioinformatics, and other related fields. The journal provides a platform for delivering scientific information to investigators, scientists, physicians, lecturers, and students. FBL welcomes submissions of original research articles, reviews, systematic reviews, short communications, and editorials.
5 Days
Time to First Decision
 
35 Days
Review Time
 
75 Days
Submission to Acceptance

Highlights

Editor's Pick

View All
Open Access Review
2950
539
18
Open Access Original Research

Oxidative and Excitatory Neurotoxic Stresses in CRISPR/Cas9-Induced Kynurenine Aminotransferase Knockout Mice: A Novel Model for Despair-Based Depression and Post-Traumatic Stress Disorder

Ágnes Szabó, Zsolt Galla, Eleonóra Spekker, Mónika Szűcs, Diána Martos, Keiko Takeda, Kinuyo Ozaki, Hiromi Inoue, Sayo Yamamoto, József Toldi, Etsuro Ono, László Vécsei, Masaru Tanaka

Front. Biosci. (Landmark Ed) 2025, 30(1), 25706; https://doi.org/10.31083/FBL25706

(This article belongs to the Special Issue Exploring Pathomechanisms, Novel Targets, and New Interventions for Neurological and Neuropsychiatric Disorders)

2330
396
18

Editor's Pick

View All
Open Access Review
2950
539
18
Open Access Original Research

Oxidative and Excitatory Neurotoxic Stresses in CRISPR/Cas9-Induced Kynurenine Aminotransferase Knockout Mice: A Novel Model for Despair-Based Depression and Post-Traumatic Stress Disorder

Ágnes Szabó, Zsolt Galla, Eleonóra Spekker, Mónika Szűcs, Diána Martos, Keiko Takeda, Kinuyo Ozaki, Hiromi Inoue, Sayo Yamamoto, József Toldi, Etsuro Ono, László Vécsei, Masaru Tanaka

Front. Biosci. (Landmark Ed) 2025, 30(1), 25706; https://doi.org/10.31083/FBL25706

(This article belongs to the Special Issue Exploring Pathomechanisms, Novel Targets, and New Interventions for Neurological and Neuropsychiatric Disorders)

2330
396
18
Latest Articles
Most Read
Funding
Open Access Review

Keap1-Nrf2 Signaling Pathway-Mediated Antioxidant Defense in Neurodegenerative Diseases: Mechanisms and Traditional Chinese Medicine Therapeutic Strategies

Wentao Chen, Jiying Wang, Qing Li, Linao Zhang, Xue Wu, Shifang Luo, Yuhuan Xie, Peixin Guo

Front. Biosci. (Landmark Ed) 2026, 31(4), 45233; https://doi.org/10.31083/FBL45233 (registering DOI)

(This article belongs to the Special Issue Exploring Pathomechanisms, Novel Targets, and New Interventions of Neurological and Neuropsychiatric Disorders - Volume 2)

9
2
Open Access Review
4
2
Open Access Original Research
5
2
Open Access Review
3
2
Open Access Opinion
44
6
Open Access Original Research
62
2
Open Access Original Research
78
3
View All